Zobrazeno 1 - 10
of 191
pro vyhledávání: '"Jasmin, Bektic"'
Autor:
Igor Tsaur, Isabel Heidegger, Jasmin Bektic, Mona Kafka, Roderick C. N. van denBergh, Jarmo C. B. Hunting, Anita Thomas, Maximilian P. Brandt, Thomas Höfner, Eliott Debedde, Constance Thibault, Paola Ermacora, Fabio Zattoni, Silvia Foti, Alexander Kretschmer, Guillaume Ploussard, Severin Rodler, Gunhild vonAmsberg, Derya Tilki, Christian Surcel, Barak Rosenzweig, Moran Gadot, Giorgio Gandaglia, Robert Dotzauer, EAU‐YAU Prostate Cancer Working Party
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6354-6364 (2021)
Abstract Background Docetaxel (D) or secondary hormonal therapy (SHT) each combined with androgen deprivation therapy (ADT) represent possible treatment options in males with metastasized hormone‐sensitive prostate cancer (mHSPC). Real‐world data
Externí odkaz:
https://doaj.org/article/4f90cb66721a47429e5f32f3076f9cd7
Autor:
Michael Ladurner, Manuel Wieser, Andrea Eigentler, Martin Seewald, Gabriele Dobler, Hannes Neuwirt, Mona Kafka, Isabel Heidegger, Wolfgang Horninger, Jasmin Bektic, Helmut Klocker, Peter Obrist, Iris E. Eder
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 1004 (2021)
Since tissue material is often lacking in metastatic prostate cancer (mPCa), there is increasing interest in using liquid biopsies for treatment decision and monitoring therapy responses. The purpose of this study was to validate the usefulness of ci
Externí odkaz:
https://doaj.org/article/4792f5660960439c989b0d0e64ed5089
Autor:
Igor Tsaur, Jarmo C B Hunting, Alexander Kretschmer, Derya Tilki, Giorgio Gandaglia, Jasmin Bektic, Hendrik Borgmann, Robert Dotzauer, Roderick C.N. van den Bergh, Guillaume Ploussard, Isabel Heidegger, Silvia Foti
Publikováno v:
European Urology Focus. 7:1308-1315
Background: Besides second-generation hormone therapy (sHT), upfront docetaxel along with androgen deprivation therapy is the current standard of care for metastasized hormone-sensitive prostate cancer (mHSPC). Evidence on second-line therapy upon pr
Autor:
Mona Kafka, Thomas Burtscher, Josef Fritz, Maximilian Schmitz, Jasmin Bektic, Michael Ladurner, Wolfgang Horninger, Isabel Heidegger
Publikováno v:
World Journal of Urology.
Propose Using Docetaxel chemotherapy or new hormonal agents (NHT) to intensify upfront systemic therapy resulted in improved survival rates compared to androgen deprivation monotherapy (ADT). Hence, combination therapies have become the new standard
Autor:
Michael Lotterstätter, Stephan Seklehner, Florian Wimpissinger, Jozsef Gombos, Jasmin Bektic, Philipp Stolzlechner, Sarah Laimer, Thomas R. W. Herrmann, Stephan Madersbacher, Lukas Lusuardi, Manuela Sieberer, Christian Ramesmayer
Publikováno v:
World journal of urology. 40(12)
Purpose To determine the safety and efficacy of transurethral resection of the prostate (TUR-P) in patients 85 years or older. Methods In this retrospective, multicentre study, patients equal or older than 85 years at the time of surgery (2015–2020
Autor:
Peter Obrist, Jasmin Bektic, Manuel Wieser, Wolfgang Horninger, Michael Ladurner, Andrea Eigentler, Martin Seewald, Mona Kafka, Iris E. Eder, Isabel Heidegger, Gabriele Dobler, Hannes Neuwirt, Helmut Klocker
Publikováno v:
Biomedicines
Volume 9
Issue 8
Biomedicines, Vol 9, Iss 1004, p 1004 (2021)
Volume 9
Issue 8
Biomedicines, Vol 9, Iss 1004, p 1004 (2021)
Since tissue material is often lacking in metastatic prostate cancer (mPCa), there is increasing interest in using liquid biopsies for treatment decision and monitoring therapy responses. The purpose of this study was to validate the usefulness of ci
Autor:
Isabel Heidegger, Viktor Skradski, Eberhard Steiner, Helmut Klocker, Renate Pichler, Andreas Pircher, Wolfgang Horninger, Jasmin Bektic
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0115537 (2015)
BACKGROUND:Active surveillance (AS) is increasingly offered to patients with low risk prostate cancer. The present study was conducted to evaluate the risk of tumor under-grading and -staging for AS eligibility. Moreover, we analyzed possible biomark
Externí odkaz:
https://doaj.org/article/461fa6057ded47c0985d8ae619a5a690
Autor:
Isabel Heidegger, Josef Fritz, Helmut Klocker, Renate Pichler, Jasmin Bektic, Wolfgang Horninger
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0134134 (2015)
To reduce the number of unnecessary biopsies in patients with benign prostatic disease, however, without missing significant PCa the present study re-evaluates the age-dependent PSA cut-offs in the Tyrol Prostate Cancer (PCa) early detection program.
Externí odkaz:
https://doaj.org/article/b8b52c392edf44f58b5de861df59a0e4
Autor:
Jasmin Bektic, Thomas Burtscher
Publikováno v:
Journal für Urologie und Urogynäkologie/Österreich. 26:114-120
„Lower urinary tract symptoms“ (LUTS) gehoren zu den haufigsten Beschwerden der Patienten in der taglichen urologischen Praxis, wobei eine benigne Prostatavergroserung die haufigste Ursache fur LUTS bei Mannern darstellt. Fur die Therapie, die nu
Autor:
Fabian Steinkohl, Jasmin Bektic, Renate Pichler, Leonhard Gruber, Anna Luger, Friedrich Aigner, Isabel Heidegger-Pircher, Margarethe Hochleitner
Publikováno v:
Transl Androl Urol
BACKGROUNDS: The number of practicing female urologists is rising. The aim of this study is to evaluate the acceptance of female urologists by male patients and their partners. METHODS: Men who underwent a prostate MRI or a prostate biopsy between Ja
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9539c68cc05b27493e2aff00c7226895
https://europepmc.org/articles/PMC8350231/
https://europepmc.org/articles/PMC8350231/